Carbostesin 0,5 % hyperbar, Injektionslösung

7680455900464 CH-45590 Injektionslösung
Carbostesin 0,5 % hyperbar, Injektionslösung
Carbostesin 0,5 % hyperbar, Injektionslösung
Carbostesin 0,5 % hyperbar, Injektionslösung
1 / 3
google

Article details

Package size
5 x 4
Selling units
5
Measure
ml
Galenic form
Injektionslösung
Galenic group
Injektion/Infusion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
24/03/2020
Summary of Product Characteristics
Français
24/03/2020
Summary of Product Characteristics
Italien
24/03/2020

Detailed composition

Substance Quantity Type Category
(N/A)
5.0 MG Substance Wirkstoff (Principe actif)
bupivacaini hydrochloridum monohydricum
- Substance WIZUS
(N/A)
80.0 MG Substance HNIDK
(N/A)
- Substance HNIDK
natrii hydroxidum
- Substance HNIDK
acidum hydrochloridum
- Substance HNIDK
natrium
- Substance HBESI

Authorization holder

Aspen Pharma Schweiz GmbH

6340 Baar

Authorization information

Swissmedic authorization number
45590
Drug name
Carbostesin 0,5 % hyperbar, Injektionslösung
Galenic form
LSPA
ATC Code
N01BB01
Authorization status
Z
Dispensing category
B
First authorization
26/08/1986
Authorization expiration date
31/12/9999
IT Number
01.02.2.
Domain
Human medicine
Field of application
Lokalanästhetikum

Package details

Description (FR)
CARBOSTESIN 0.5% hyperbare 20 mg/4ml 5 amp 4 ml
Description (DE)
CARBOSTESIN 0.5% hyperbar 20 mg/4ml 5 Amp 4 ml
Market launch
26/08/1986
Narcotic (BTM)
No

Other package sizes (1)

CARBOSTESIN hyperbare sol inj 0.5 % 25 amp 4 ml
None None
GTIN: 7680455900549
Not in V1